Want to see TSE:AVCR full AI Analyst Report?
Avricore Health (AVCR) Ratios
16 Followers
Avricore Health Ratios
TSE:AVCR's free cash flow for Q2 2026 was C$-477.28K. For the 2026 fiscal year, TSE:AVCR's free cash flow was decreased by C$-187.00 and operating cash flow was C$-477.09K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.11 | 4.78 | 1.46 | 2.37 | 25.56 |
| Quick Ratio | 2.11 | 4.78 | 1.42 | 2.37 | 25.56 |
| Cash Ratio | 1.31 | 3.42 | 0.52 | 1.03 | 23.83 |
| Solvency Ratio | -9.91 | -0.66 | -0.53 | -1.05 | -20.01 |
| Operating Cash Flow Ratio | -4.55 | 3.04 | 1.25 | -0.72 | -14.61 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 16.51 | -10.95 | -30.85 |
| Net Current Asset Value | C$ 192.77K | C$ 1.25M | C$ 244.34K | C$ 826.24K | C$ 2.07M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.45 | 1.17 | 1.26 | 1.31 | 1.04 |
| Debt Service Coverage Ratio | -136.01 | -20.14 | -5.98 | -13.86 | -19.30 |
| Interest Coverage Ratio | -151.48 | 13.47 | -115.15 | -149.39 | -38.57 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.19 | 5.43 | 0.86 | 0.92 | 1.20 |
| Profitability Margins | |||||
| Gross Profit Margin | 44.27% | 39.29% | 34.53% | 25.83% | 24.85% |
| EBIT Margin | -256.15% | -13.76% | -19.95% | -45.96% | -1354.05% |
| EBITDA Margin | -230.00% | -4.36% | -7.89% | -35.61% | -1339.41% |
| Operating Profit Margin | -256.15% | 2.91% | -19.85% | -45.80% | -1420.92% |
| Pretax Profit Margin | -348.16% | -13.98% | -20.12% | -46.27% | -1390.90% |
| Net Profit Margin | -348.16% | -13.98% | -20.12% | -46.27% | -1390.90% |
| Continuous Operations Profit Margin | -348.16% | -13.98% | -20.12% | -46.27% | -1390.90% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 135.92% | -480.08% | 101.36% | 101.03% | 97.89% |
| Return on Assets (ROA) | -330.08% | -29.10% | -27.63% | -31.85% | -74.87% |
| Return on Equity (ROE) | -477.14% | -34.00% | -34.90% | -41.66% | -77.75% |
| Return on Capital Employed (ROCE) | -351.04% | 7.08% | -34.44% | -41.23% | -79.43% |
| Return on Invested Capital (ROIC) | -351.04% | 7.08% | -33.76% | -40.41% | -78.01% |
| Return on Tangible Assets | -330.08% | -29.87% | -28.14% | -32.22% | -75.92% |
| Earnings Yield | -36.70% | -12.13% | -4.14% | -2.65% | -11.53% |
| Efficiency Ratios | |||||
| Receivables Turnover | 14.30 | 11.41 | 8.15 | 2.30 | 1.34 |
| Payables Turnover | 1.72 | 11.35 | 5.32 | 6.24 | 2.07 |
| Inventory Turnover | 0.00 | 5730.62 | 110.36 | 5633197501054976.00 | 0.00 |
| Fixed Asset Turnover | 2.71 | 7.29 | 2.03 | 1.60 | 1.35 |
| Asset Turnover | 0.95 | 2.08 | 1.37 | 0.69 | 0.05 |
| Working Capital Turnover Ratio | 0.74 | 6.40 | 6.51 | 1.22 | 0.18 |
| Cash Conversion Cycle | -186.10 | -0.09 | -20.47 | 100.54 | 96.18 |
| Days of Sales Outstanding | 25.52 | 32.00 | 44.79 | 159.01 | 272.09 |
| Days of Inventory Outstanding | 0.00 | 0.06 | 3.31 | 0.00 | 0.00 |
| Days of Payables Outstanding | 211.62 | 32.16 | 68.57 | 58.47 | 175.91 |
| Operating Cycle | 25.52 | 32.07 | 48.10 | 159.01 | 272.09 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | 0.01 | 0.01 | -0.00 | -0.01 |
| Free Cash Flow Per Share | -0.01 | 0.01 | -0.00 | -0.02 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | -6.91 | 4.89 | 0.63 | -0.37 | -8.79 |
| Capital Expenditure Coverage Ratio | -6.91 | 4.89 | 0.63 | -0.37 | -8.79 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 16.51 | -10.95 | -30.85 |
| Operating Cash Flow to Sales Ratio | -1.48 | 0.21 | 0.19 | -0.25 | -10.05 |
| Free Cash Flow Yield | -17.86% | 14.49% | -2.28% | -5.31% | -9.28% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.72 | -8.21 | -24.14 | -37.67 | -8.67 |
| Price-to-Sales (P/S) Ratio | 9.49 | 1.15 | 4.86 | 17.43 | 120.66 |
| Price-to-Book (P/B) Ratio | 13.00 | 2.80 | 8.42 | 15.69 | 6.74 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.60 | 6.90 | -43.80 | -18.84 | -10.78 |
| Price-to-Operating Cash Flow Ratio | -6.41 | 5.49 | 25.63 | -70.41 | -12.01 |
| Price-to-Earnings Growth (PEG) Ratio | -0.02 | 1.92 | 1.45 | 0.69 | 1.68 |
| Enterprise Value Multiple | -3.94 | -21.04 | -60.66 | -48.03 | -7.81 |
| Enterprise Value | 4.84M | 4.38M | 16.69M | 30.25M | 12.84M |
| EV to EBITDA | -3.94 | -21.04 | -60.66 | -48.03 | -7.81 |
| EV to Sales | 9.06 | 0.92 | 4.79 | 17.10 | 104.59 |
| EV to Free Cash Flow | -5.35 | 5.49 | -43.18 | -18.48 | -9.34 |
| EV to Operating Cash Flow | -6.12 | 4.36 | 25.27 | -69.08 | -10.41 |
| Tangible Book Value Per Share | 0.00 | 0.02 | 0.02 | 0.02 | 0.02 |
| Shareholders’ Equity Per Share | 0.00 | 0.02 | 0.02 | 0.02 | 0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.01 | 0.05 | 0.04 | 0.02 | 0.00 |
| Net Income Per Share | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.36 | 1.02 | 1.01 | 1.01 | 1.03 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 2.47 | 0.37 | 0.53 | 0.57 | 13.89 |
| Stock-Based Compensation to Revenue | 0.53 | 0.11 | 0.20 | 0.19 | 4.04 |
| Income Quality | 0.42 | -1.50 | -0.94 | 0.54 | 0.72 |
Currency in CAD
